share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Davis Robert M

SEC announcement ·  Feb 16 05:03
Summary by Futu AI
Merck & Co's Chairman, CEO & President, Davis Robert M, completed a series of stock transactions on February 13 and 14, 2024. The executive sold a total of 235,021 shares of common stock at prices ranging from $125.3993 to $126.3733, resulting in a total market value of $29,538,998.07. Prior to the sales, Davis acquired the same number of shares through the exercise of derivative securities at prices between $73.73 and $75.36. Following these transactions, Davis Robert M's direct holdings in Merck & Co amounted to 348,326.757 shares of common stock.
Merck & Co's Chairman, CEO & President, Davis Robert M, completed a series of stock transactions on February 13 and 14, 2024. The executive sold a total of 235,021 shares of common stock at prices ranging from $125.3993 to $126.3733, resulting in a total market value of $29,538,998.07. Prior to the sales, Davis acquired the same number of shares through the exercise of derivative securities at prices between $73.73 and $75.36. Following these transactions, Davis Robert M's direct holdings in Merck & Co amounted to 348,326.757 shares of common stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.